Pharmacokinetic and pharmacodynamic evaluation of ibrutinib for the treatment of chronic lymphocytic leukemia: rationale for lower doses.
about
Pharmacokinetic and pharmacodynamic evaluation of ibrutinib for the treatment of chronic lymphocytic leukemia: rationale for lower doses.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Pharmacokinetic and pharmacody ...... ia: rationale for lower doses.
@en
Pharmacokinetic and pharmacody ...... ia: rationale for lower doses.
@nl
type
label
Pharmacokinetic and pharmacody ...... ia: rationale for lower doses.
@en
Pharmacokinetic and pharmacody ...... ia: rationale for lower doses.
@nl
prefLabel
Pharmacokinetic and pharmacody ...... ia: rationale for lower doses.
@en
Pharmacokinetic and pharmacody ...... ia: rationale for lower doses.
@nl
P2860
P1476
Pharmacokinetic and pharmacody ...... ia: rationale for lower doses.
@en
P2093
Prithviraj Bose
Varsha V Gandhi
P2860
P356
10.1080/17425255.2016.1239717
P407
P577
2016-10-11T00:00:00Z